Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
2023 · New England Journal of Medicine · 626 citations
https://doi.org/10.1056/nejmoa2302312
L
Lindsey Beffa
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
849
Citations
8
h-index
6
i10-index
Lindsey Beffa is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & BRCA gene mutations in cancer. The author has an h-index of 8, co-authored 42 publications.
ORCID: 0000-0003-0410-8169Papers by this author
worksThe similarities and differences between mesonephric carcinoma and mesonephric-like carcinoma: Two cases
2021 · Gynecologic Oncology Reports · 5 citations
https://doi.org/10.1016/j.gore.2021.100856
Treatment patterns and outcomes of locally advanced endometrial cancer patients treated with neoadjuvant radiation
2024 · Gynecologic Oncology · 0 citations
https://doi.org/10.1016/j.ygyno.2024.07.543
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat